Skip to main content
TipRanks
Go Ultimate75% OFF

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Income Statement

7 Followers

GlaxoSmithKline Pharmaceuticals Limited Income Statement

Last quarter (Q2 2027), GlaxoSmithKline Pharmaceuticals Limited's total revenue was ₹11.84B, an increase of 20.78% from the same quarter last year. In Q2, GlaxoSmithKline Pharmaceuticals Limited's net income was ₹3.36B. See GlaxoSmithKline Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementMar 26Mar 25Mar 24Mar 23Mar 22
₹ 38.22B₹ 37.26B₹ 34.42B₹ 32.26B₹ 32.64B
₹ 16.65B₹ 22.53B₹ 20.22B₹ 18.68B₹ 18.14B
₹ 11.38B₹ 11.39B₹ 11.83B₹ 11.19B₹ 11.16B
Depreciation and Amortization₹ 664.40M₹ 667.92M₹ 696.80M₹ 657.67M₹ 681.86M
₹ 14.75B₹ 13.28B₹ 8.88B₹ 9.04B₹ 8.49B
₹ 12.60B₹ 11.14B₹ 8.38B₹ 7.48B₹ 6.99B
₹ 1.46B₹ 1.46B₹ -222.98M₹ 879.74M₹ 748.15M
₹ 14.06B₹ 12.60B₹ 8.16B₹ 8.36B₹ 7.79B
₹ 10.36B₹ 9.28B₹ 5.90B₹ 6.11B₹ 16.95B
Per Share Metrics
Basic EPS₹ 61.15₹ 54.76₹ 34.83₹ 35.87₹ 100.04
Diluted EPS₹ 61.15₹ 54.76₹ 34.83₹ 35.87₹ 100.04
Weighted Average Shares Outstanding169.42M169.41M169.41M169.41M169.41M
Weighted Average Shares Outstanding (Diluted)169.42M169.41M169.41M169.41M169.41M

Currency in INR

GlaxoSmithKline Pharmaceuticals Limited Earnings and Revenue History

015B30B45B0 %20 %40 %60 %EarningsProfit Margin2017201820192020202120222023202420252026RevenueEarningsProfit Margin